Syed Faaiz Enam

ORCID: 0000-0002-5320-6809
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Traumatic Brain Injury and Neurovascular Disturbances
  • Mesenchymal stem cell research
  • Thermal Regulation in Medicine
  • Glioma Diagnosis and Treatment
  • Hip and Femur Fractures
  • Extracellular vesicles in disease
  • Immune cells in cancer
  • Anesthesia and Neurotoxicity Research
  • 3D Printing in Biomedical Research
  • Nerve injury and regeneration
  • Traumatic Brain Injury Research
  • Glycogen Storage Diseases and Myoclonus
  • Genetics and Neurodevelopmental Disorders
  • Poisoning and overdose treatments
  • Genomics and Phylogenetic Studies
  • EEG and Brain-Computer Interfaces
  • Microbial Community Ecology and Physiology
  • Lysosomal Storage Disorders Research
  • Dietary Effects on Health
  • AI-based Problem Solving and Planning
  • Bacteriophages and microbial interactions
  • Neural dynamics and brain function
  • Cutaneous Melanoma Detection and Management
  • Human Motion and Animation
  • Photoreceptor and optogenetics research

The University of Texas Southwestern Medical Center
2022-2025

Southwestern Medical Center
2023-2025

Duke University
2017-2022

Pratt Institute
2021-2022

Durham Technical Community College
2021

Aga Khan University
2014-2018

University at Buffalo, State University of New York
2018

Aga Khan University
2018

Aga Khan University Hospital
2016

Beth Israel Deaconess Medical Center
2012

Neural stem cells (NSCs) possess great potential for neural tissue repair after traumatic injuries to the central nervous system (CNS). However, poor survival and self-renewal of NSCs injury severely limits its therapeutic potential. Sulfated chondroitin sulfate glycosaminoglycans (CS-GAGs) linked CS proteoglycans (CSPGs) in brain extracellular matrix (ECM) have ability bind potentiate trophic factor efficacy, promote NSC vivo. In this study, we investigated CS-GAG hydrogels composed...

10.1021/acs.bioconjchem.5b00397 article EN Bioconjugate Chemistry 2015-10-06

Appropriately modulating inflammation after traumatic brain injury (TBI) may prevent disabilities for the millions of those inflicted annually. In TBI, cellular mediators inflammation, including macrophages and microglia, possess a range phenotypes relevant an immunomodulatory therapeutic approach. It is thought that early phenotypic modulation these cells will have cascading healing effect. fact, anti-inflammatory, "M2-like" macrophage phenotype TBI has been associated with neurogenesis,...

10.1186/s12974-020-01860-y article EN cc-by Journal of Neuroinflammation 2020-06-20

Introduction The apparent diffusion coefficient (ADC) sequence is based on the properties of water molecules within tissues and correlates with tissue cellularity. ADC may have a role in predicting tumor grade for gliomas, turn assist identifying biopsy sites. purpose this investigation was to assess competence preoperative values grades. Methods This retrospective investigation. We calculated areas greatest restriction solid components, we recorded pattern contrast enhancement. Pathology...

10.7759/cureus.2284 article EN Cureus 2018-03-07

Background Data on the evaluation of Rotterdam Computed Tomography Classification (RCTS) as a predictor outcomes in patients undergoing decompressive craniectomy (DC) for trauma is limited and lacks clarity. Objective To explore role RCTS predicting unfavourable outcomes, including mortality DC head trauma. Methods This was an observational cohort study conducted from 1 January 2009 to 31 March 2013. CT scans adults with prior emergency were scored according RCTS. A receiver operating...

10.3109/02688697.2016.1139047 article EN British Journal of Neurosurgery 2016-02-01

Patients with glioblastoma (GBM) have limited options and require novel approaches to treatment. Here, we studied deployed nonfreezing "cytostatic" hypothermia stunt GBM growth. This growth-halting method contrasts ablative, cryogenic that kills both neoplastic infiltrated healthy tissue. We investigated degrees of in vitro identified a cytostatic window 20° 25°C. For some lines, 18 hours/day was sufficient halt division vitro. Next, fabricated an experimental tool test local two rodent...

10.1126/sciadv.abq4882 article EN cc-by-nc Science Advances 2022-11-23

We present a case of congenital malignant melanoma the scalp in neonate. The child was born through caesarean section with swelling, size tennis ball, on posterior scalp. At presentation to clinic at 25 days after birth, swelling had significantly increased and ulcerated. An excision carried out but, because extensive haemorrhage haemodynamic instability, procedure limited subtotal resection. Later on, completion flap coverage wound were performed. After an initial stable course few months,...

10.1136/bcr-2013-202588 article EN BMJ Case Reports 2014-04-23

To develop an implantable device capable of delivering intracranial cytostatic hypothermia in swine. Patients with glioblastoma (GBM) require novel approaches to treatment. We have previously demonstrated that intra-tumoral, non-freezing, 'cytostatic' hypothermia, can safely stunt GBM growth and effectively prolong survival rodents GBM. This was through a consisting thermoelectric cooler, probe, heat sink, fan. Unlike targeted therapeutics are successful preclinical models but fail clinical...

10.1212/wnl.0000000000205086 article EN Neurology 2024-04-09

The treatment of glioblastoma (GBM) presents significant challenges, with median survival rates remaining low despite standard-of-care therapies. This study expands upon the findings a novel approach to managing GBM, namely cytostatic hypothermia, through computational evaluation fully implantable system. Our proposed system utilizes multi-probe array and artificial internal circulation (AICS) achieve homogeneous cooling within brain without overheating any portion body. Finite-element...

10.1101/2024.05.13.594046 preprint EN cc-by-nc-nd bioRxiv (Cold Spring Harbor Laboratory) 2024-05-17

Abstract Survival rates for glioblastoma (GBM) patients are low due to the difficulty in eradicating all tumor cells, leading frequent recurrence. This recurrence is frequently within 2-cm from original site. Studies indicate that supra-total resection improves survival, and non-destructive local therapies show promise preventing GBM Our research demonstrates non-freezing, ‘cytostatic’ hypothermia effective against rats can be scaled pig models. method, unlike ablative cryogenic hypothermia,...

10.1093/neuonc/noae165.1004 article EN Neuro-Oncology 2024-11-01

Abstract Novel therapeutic approaches are needed for patients with glioblastoma (GBM) who otherwise have limited options. Here we studied and deployed non-freezing ‘cytostatic’ hypothermia to stunt GBM growth. This contrasts ablative, cryogenic hypothermia: a double-edged sword against tumors infiltrating healthy tissue. We investigated three grades of in vitro identified cytostatic window 20–25°C. For some glioma lines, 18 h/d was sufficient halt division . Cytostatic induced cell cycle...

10.1101/2021.03.25.436870 preprint EN bioRxiv (Cold Spring Harbor Laboratory) 2021-03-26

Abstract Chronic stimulation of and recording from the brain diseases can require expensive apparatus tedious cycles inducing rodents with anesthesia. To resolve this, we have designed fabricated a low-cost (∼$75 vs. $450) DIY rodent caging consisting commercially available 3D-printed components. This is customizable be used to rapidly prototype devices large sample sizes. Importantly, it enables continuous chronic brains awake freely moving rodents. It also opens possibilities trying...

10.1101/2021.12.16.473031 preprint EN cc-by-nc bioRxiv (Cold Spring Harbor Laboratory) 2021-12-19

Abstract Appropriately modulating inflammation after traumatic brain injury (TBI) may prevent disabilities for the millions of those inflicted annually. In TBI, cellular mediators inflammation, including macrophages and microglia, possess a range phenotypes relevant an immunomodulatory therapeutic approach. It is thought that early phenotypic modulation these cells will have cascading healing effect. fact, anti-inflammatory, “M2-like” macrophage phenotype TBI has been associated with...

10.1101/2020.01.28.918441 preprint EN cc-by-nc-nd bioRxiv (Cold Spring Harbor Laboratory) 2020-01-28
Fernanda Macedo de Oliveira Neves T. T. Leite Gdayllon Cavalcante Meneses NATALI SOUZA Alice Maria Costa Martins and 95 more Marcelo Coelho Parahyba R. E. B. Queiroz Adail Orrith Liborio Neto Ye Liu Y. Li X. Li Liming Chen Aleksei Zulkarnaev A. Vatazin S. Nikolaj Tanja Stadler Alexander Raddatz W Hübner A. Poppleton D. Fliser M. Klingele G. Castellano Angelica Intini Alessandra Stasi C. Divella P. Pontrelli M. Gigante Anna Zito Giovanni Pertosa Loreto Gesualdo G. Grandaliano Thomas C. Powell J. Peter Donnelly Hongfei Wang David G. Warnock Jorien De Loor Eric A. J. Hoste Ingrid Herck K. Francois Luc DeCrop C Clauwaert Stefanie Bracke Daisy Vermeiren Kristel Demeyere Evelyne Meyer Prasenjit Mitra Muhammad Abdur Rahim Raavi Gupta Tasrina Samnaz Samdani Sanzidur Rahman Syed Faaiz Enam Golam Mursalin Mohammad Mehfuz- E-Khoda Wasim Md Mohosin Ul Haque Saeed Iqbal Mohammad Abul Mansur G. Guglielmetti T. Cena Claudio Musetti Marco Quaglia Michèle Battista E. Radin A. Airoldi C. Izzo P. Stratta Anja Haase‐Fielitz C. Albert Sabine Westphal Jürgen Hoffmann P. R. Mertens Michael Plaß M. Westerman Rinaldo Bellomo Alan Maisel Claudio Ronco Michael Haase P.–C. Wu V.-C. Wu B. Raghavendra Prasad Brian J. F. Wong Jennifer R. St. Onge R. Rungta P. Das D. S. Ray Sanjana Gupta M. D. C. De Gracia Aranzazu González Andrés Quesada Francisco Manzano S. Carnicero Montoro Miguel Jiménez Rosemary Wangensteen A.-K. Strunk Julius J. Schmidt B. Schmidt Stefanie M. Bode‐Böger J. Martens-Lobenhoffer Thomas Welte Jan T. Kielstein Ying Wang

10.1093/ndt/gfu144 article EN Nephrology Dialysis Transplantation 2014-05-01

Abstract Survival rates for patients with glioblastoma (GBM) remain discouraging due to the near-impossibility of eradicating all tumor cells, resulting in frequent recurrence. However, studies have shown that recurrence is predominantly localized (80% cases) and survival outcomes are improved supra-total resection. Consequently, non-destructive local therapies hold promise preventing GBM We demonstrated non-freezing, 'cytostatic' hypothermia a unique effective approach against GBM. Unlike...

10.1093/neuonc/noad179.0858 article EN Neuro-Oncology 2023-11-01

Abstract As a cancer therapy, hypothermia has been used at sub-zero temperatures to cryosurgically ablate tumors. However, these can indiscriminately damage both tumorous and healthy cells. Additionally, strategies designed kill tumor typically accelerate their evolution recurrence be inevitable in cancers such as glioblastoma (GBM). To bypass limitations, here we studied the use of cytostatic tool against deployed it an aggressive rodent model GBM. identify minimal dosage ‘cytostatic...

10.1093/neuonc/noaa215.425 article EN Neuro-Oncology 2020-11-01
Coming Soon ...